Publication | Closed Access
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population
16
Citations
25
References
2023
Year
Ii TrialOncologyRadiation TherapyMedicineHead And Neck CancerPharmacotherapyNeck OncologyPharmacologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1